Non Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations [Phase 4]
A Phase 4 clinical trial evaluating dacomitinib for metastatic non-small cell lung cancer with EGFR activating mutations in India has comple…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating MAGE-A1-specific T cell receptor-transduced autologous T-cells with atezolizumab for metastatic triple-n…
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4) [Phase 2]
Phase 2 trial (PRESERVE 4) evaluating trilaciclib with docetaxel in metastatic non-small cell lung cancer was terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect [Phase 2]
Phase 2 trial evaluating immunotherapy with SBRT to sensitize PD-1 in metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating nivolumab, cabozantinib S-malate, and ipilimumab in recurrent stage IV non-small cell lung cancer has completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of immunotherapy and an mRNA vaccine in metastatic non-small cell lung cancer has completed with re…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) [Phase 2]
Phase 2 clinical trial update for INCMGA00012 in selected solid tumors, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating nivolumab with tumor-infiltrating lymphocytes in advanced non-small cell lung cancer completed with result…
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC [Phase 1, Phase 2]
A clinical trial evaluating the combination of nivolumab with ADG106 in metastatic non-small cell lung cancer is in Phase 1/2, with unknown …
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC [Phase 2]
Phase 2 trial evaluating sintilimab, anlotinib hydrochloride, and platinum-containing chemotherapy in metastatic/recurrent non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating PD-1 knockout engineered T cells in metastatic non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating carboplatin/paclitaxel with or without investigational CS-7017 in metastatic non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating safety and tolerability of cobimetinib plus GDC-0994 in patients with various advanced solid tumors, including no…